NCT05501587Recruiting
Measures of Respiratory Health Registry
Source: ClinicalTrials.gov · Last updated 15 Aug 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
There are many techniques that can allow for the quantification of lung function in children; some are being used clinically and others are under development. Many of these tools are available at BC Children's Hospital. This registry study will act as a central repository for the results of traditional and novel pulmonary function tests done at BC Children's Hospital to allow for future analysis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 11 Aug 2022
- Start date
- 11 Oct 2018
- Primary completion date
- 31 May 2028
- Lead sponsor
- University of British Columbia
- Diseases
- Cystic fibrosis
- NCT number
- NCT05501587
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 11 Oct 2018 to the primary completion date, 31 May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Requirement of supplementary oxygen to maintain oxygen saturation above 95%
- Participants with other Respiratory Disease
- Evidence of lung disease
Other
- Physical findings at the screening that would compromise the safety of the participant or the quality of the data (e.g. respiratory distress or work of breathing)
- Physical findings at screening that would compromise the safety of the participant or the quality of the research data
- Requirement of supplementary oxygen to maintain oxygen saturation above 95%
- Healthy Participants
- Inclusion criteria
- Informed consent by participant, parent, or legal guardian
- In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing
- Physical findings at screening that would compromise the safety of the participant or the quality of the research data
Who the study is looking for
- -Diagnosis of CF as evidenced by one or more clinical feature consistent with the CF phenotype or positive CF newborn screen AND one or more of the following criteria: i. A documented sweat chloride ≥ 60 mEq/L by quantitative pilocarpine iontophoresis (QPIT).
- A documented genotype with two disease-causing mutations in the CFTR gene.
- \- In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing
- Physician-diagnosed lung disease
- Informed consent by participant, parent, or legal guardian
- In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing
Criteria the registry did not label
- Participants with CF
Age in the registry: 0 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| British Columbia Children's Hospital Coordinator of this site? Confirm its status | Vancouver | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.